Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

2.

Investigation into the controversial association of Streptococcus gallolyticus with colorectal cancer and adenoma.

Abdulamir AS, Hafidh RR, Mahdi LK, Al-jeboori T, Abubaker F.

BMC Cancer. 2009 Nov 19;9:403. doi: 10.1186/1471-2407-9-403.

3.

Detection of colorectal cancer cells from feces using quantitative real-time RT-PCR for colorectal cancer diagnosis.

Koga Y, Yasunaga M, Moriya Y, Akasu T, Fujita S, Yamamoto S, Kozu T, Baba H, Matsumura Y.

Cancer Sci. 2008 Oct;99(10):1977-83. doi: 10.1111/j.1349-7006.2008.00954.x.

4.

Potential usefulness of detecting cyclooxygenase 2 messenger RNA in feces for colorectal cancer screening.

Kanaoka S, Yoshida K, Miura N, Sugimura H, Kajimura M.

Gastroenterology. 2004 Aug;127(2):422-7.

PMID:
15300574
5.

Fecal cyclooxygenase 2 plus matrix metalloproteinase 7 mRNA assays as a marker for colorectal cancer screening.

Takai T, Kanaoka S, Yoshida K, Hamaya Y, Ikuma M, Miura N, Sugimura H, Kajimura M, Hishida A.

Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1888-93. doi: 10.1158/1055-9965.EPI-08-0937.

6.

Effects of cyclooxygenase-2 inhibition on serum and tumor gastrins and expression of apoptosis-related proteins in colorectal cancer.

Konturek PC, Rembiasz K, Burnat G, Konturek SJ, Tusinela M, Bielanski W, Rehfeld J, Karcz D, Hahn E.

Dig Dis Sci. 2006 Apr;51(4):779-87.

PMID:
16615003
7.

Progastrin and cyclooxygenase-2 in colorectal cancer.

Konturek PC, Bielanski W, Konturek SJ, Hartwich A, Pierzchalski P, Gonciarz M, Marlicz K, Starzynska T, Zuchowicz M, Darasz Z, Götze JP, Rehfeld JF, Hahn EG.

Dig Dis Sci. 2002 Sep;47(9):1984-91.

PMID:
12353842
8.

Expression of cyclooxygenase-2 parallels expression of interleukin-1beta, interleukin-6 and NF-kappaB in human colorectal cancer.

Maihöfner C, Charalambous MP, Bhambra U, Lightfoot T, Geisslinger G, Gooderham NJ; Colorectal Cancer Group..

Carcinogenesis. 2003 Apr;24(4):665-71.

PMID:
12727794
9.

Methylation status of genes in non-neoplastic mucosa from patients with ulcerative colitis-associated colorectal cancer.

Garrity-Park MM, Loftus EV Jr, Sandborn WJ, Bryant SC, Smyrk TC.

Am J Gastroenterol. 2010 Jul;105(7):1610-9. doi: 10.1038/ajg.2010.22. Epub 2010 Feb 16.

PMID:
20160714
10.

Factors that contribute to faecal cyclooxygenase-2 mRNA expression in subjects with colorectal cancer.

Hamaya Y, Yoshida K, Takai T, Ikuma M, Hishida A, Kanaoka S.

Br J Cancer. 2010 Mar 2;102(5):916-21. doi: 10.1038/sj.bjc.6605564. Epub 2010 Feb 9.

11.

Impact of MTHFR gene C677T polymorphism on Bcl-2 gene methylation and protein expression in colorectal cancer.

Zhu Q, Jin Z, Yuan Y, Lu Q, Ge D, Zong M.

Scand J Gastroenterol. 2011 Apr;46(4):436-45. doi: 10.3109/00365521.2010.537682. Epub 2010 Dec 6.

PMID:
21128871
12.
13.

miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer.

Ma Y, Zhang P, Wang F, Zhang H, Yang J, Peng J, Liu W, Qin H.

Gut. 2012 Oct;61(10):1447-53. doi: 10.1136/gutjnl-2011-301122. Epub 2011 Nov 3.

PMID:
22052060
14.

Characterisation of cytokine mRNA expression in tumour-infiltrating mononuclear cells and tumour cells freshly isolated from human colorectal carcinomas.

Csiszár A, Szentes T, Haraszti B, Zou W, Emilie D, Petrányi G, Pócsik E.

Eur Cytokine Netw. 2001 Mar;12(1):87-96.

15.

Molecular basis of colorectal cancer - role of gastrin and cyclooxygenase-2.

Hartwich J, Konturek SJ, Pierzchalski P, Zuchowicz M, Konturek PC, Bielański W, Marlicz K, Starzyńska T, Ławniczak M.

Med Sci Monit. 2001 Nov-Dec;7(6):1171-81.

PMID:
11687726
16.

Reduced expression of microenvironmental Th1 cytokines accompanies adenomas-carcinomas sequence of colorectum.

Cui G, Goll R, Olsen T, Steigen SE, Husebekk A, Vonen B, Florholmen J.

Cancer Immunol Immunother. 2007 Jul;56(7):985-95. Epub 2006 Dec 8.

PMID:
17160410
17.

Digital analysis of the expression levels of multiple colorectal cancer-related genes by multiplexed digital-PCR coupled with hydrogel bead-array.

Qi Z, Ma Y, Deng L, Wu H, Zhou G, Kajiyama T, Kambara H.

Analyst. 2011 Jun 7;136(11):2252-9. doi: 10.1039/c0an00976h. Epub 2011 Apr 21.

PMID:
21509397
18.

Strong HLA-DR antigen expression on cancer cells relates to better prognosis of colorectal cancer patients: Possible involvement of c-myc suppression by interferon-gamma in situ.

Matsushita K, Takenouchi T, Shimada H, Tomonaga T, Hayashi H, Shioya A, Komatsu A, Matsubara H, Ochiai T.

Cancer Sci. 2006 Jan;97(1):57-63.

19.

The correlation between IGF-II and Bcl-2 expression in colorectal adenocarcinoma.

Zhang MS, Hu AH, Qiu H, Xiong HH, Chen Y.

Med Oncol. 2012 Jun;29(2):928-32. doi: 10.1007/s12032-011-9881-4. Epub 2011 Mar 6.

PMID:
21380782
20.

Detection of hypermethylated DNA or cyclooxygenase-2 messenger RNA in fecal samples of patients with colorectal cancer or polyps.

Leung WK, To KF, Man EP, Chan MW, Hui AJ, Ng SS, Lau JY, Sung JJ.

Am J Gastroenterol. 2007 May;102(5):1070-6. Epub 2007 Mar 22.

PMID:
17378912

Supplemental Content

Support Center